MUMBAI, Feb 28 (Reuters) - Dabur Pharma Ltd <DABR.BO>, a
maker of anti-cancer drugs, is in talks with a German drug
company for a partnership or a possible sale, the Economic Times
newspaper said on Thursday quoting anonymous sources.
The German firm was not named by the paper.
"There is no move to induct any partner," the paper quoted
Dabur's chief executive officer, Ajay Vij as saying. "We are in
touch with many companies across the globe for hundreds of
things, but this is pure speculation".
The sale or partnership was one of several options that Dabur
was considering, including inducting a private equity or a
strategic investor and a strategic alliance with a foreign
company, the paper said, citing an anonymous industry source.
Last year, Dabur group firm Dabur Pharma sold its
non-oncology drugs business to Alembic Ltd <ALMC.BO>, as part of
its strategy to focus completely on cancer treatment drugs.
(Reporting by Bharghavi Nagaraju; Editing by Ramya Venugopal)
(([email protected]; +91 22 6636 9059; Reuters
Messaging: [email protected]))
Keywords: DABUR/SALE